DIA 48th Annual Meeting
Click here to go to the previous page
Accelerating Cancer Clinical Trials
Track : Track 22: White Paper Showcase
Program Code: 398
Date: Wednesday, June 27, 2012
Time: 3:30 PM to 5:00 PM  EST
 Martin Lee, DAVA Oncology, LP, United States
 Mark Levonyak, DAVA Oncology, LP, United States
Slower than anticipated enrollment in cancer clinical trials is a common problem. In this white paper showcase, we will describe the unique challenges in cancer trials and efforts that have been made to increase enrollment. Recommendations for best practice and areas for further research will be highlighted.

Brought to you by DAVA Oncology, LP.

**Attendee badges scanned for this White Paper Showcase will be shared with the Company hosting this offering. If you prefer not to have your badge scanned, please inform the DIA staff member.

Learning Objectives:
Describe the unique challenges encountered conducting clinical research in cancer patients
Discuss the critical importance of site selection to successful trial enrollment
Identify best practices for accelerating enrollment in cancer clinical trials.

Handout Online